Three things health execs need to know about CAR T-cell therapy – ModernMedicine
Three things health execs need to know about CAR T-cell therapyModernMedicineLocke notes that these were “very refractory patients” and historical data holds that they should have no more than six months to live and a less than one in 10 chance of havi… Continue reading
